Jinming Yu: Clinical Trials

1 trial sponsored by Jinming Yu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow Jinming Yu: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy
TQB2450 Injection + Anlotinib Hydrochloride Capsules - Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy
Phase 1UnknownJinming Yu202023-05-302023-07-12

Countries

China (1)

Results publications

PMID 40114144